DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

13.53 -0.14 (-1.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $13.53 -1.02%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.43
Previous Close $13.67
Daily Range $13.40 - $13.59
52-Week Range $8.57 - $20.29
Market Cap $1.0B
P/E Ratio -20.10
Dividend (Yield) $0.00 (0.0%)
Volume 453,952
Average Daily Volume 528,062
Current FY EPS -$0.78

Sector

Healthcare

Industry

Drugs

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

Can You Still Ride This Month's 3 Biggest Winners To Greater Gains?

Biotech dominates in January as Intercept, Cell Therapeutics, and Neurocrine all surge after good drug-trial news.

2 Biotechs Race To Treat Movement Disorders

Neurocrine In "Hurry Up And Wait" Mode

Neurocrine Biosciences' (NBIX) CEO Kevin Gorman Presents at Bank of America Merrill Lynch 2014 Healt

Neurocrine Biosciences' (NBIX) CEO Kevin Gorman Presents at Bank of America Merrill Lynch 2014 Health Care Conference (Transcript)

Neurocrine Biosciences' (NBIX) CEO Kevin Gorman on Deutsche Bank 39th Annual Health Care Conference

Neurocrine Biosciences' (NBIX) CEO Kevin Gorman on Deutsche Bank 39th Annual Health Care Conference (Transcript)

Bullish Two Hundred Day Moving Average Cross - NBIX

Neurocrine Biosciences' CEO Discusses Q1 2014 Results - Earnings Call Transcript

Neurocrine Biosciences Inc. Stock Downgraded (NBIX)

Neurocrine Biosciences Is Now Oversold (NBIX)

Neurocrine Biosciences (NBIX) Shares Cross Below 200 DMA

Commit To Purchase Neurocrine Biosciences At $11, Earn 23.9% Annualized Using Options

See More NBIX News...

NBIX's Top Competitors

NBIX $13.53 (-1.02%)
Current stock: NBIX
AMGN $122.84 (0.47%)
Current stock: AMGN
GILD $89.84 (-0.77%)
Current stock: GILD
BIIB $335.45 (-0.40%)
Current stock: BIIB